tislelizUMaB in canceR Patients With molEcuLar residuaL Disease

NCT06332274 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

717

Enrollment

OTHER

Sponsor class

Conditions

Cancer
Lung Cancer
Colo-rectal Cancer
Pancreas Cancer
Soft Tissue Sarcoma

Interventions

DRUG: Tislelizumab
OTHER: Blood sampling
DRUG: Placebo

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris

Collaborators

[object Object]
[object Object]